86 related articles for article (PubMed ID: 215532)
1. Autoantibodies (cold lymphocytotoxins, antiactin antibodies and antinuclear factors) in nasopharyngeal carcinoma patients.
Lamelin JP; de-The G; Revillard JP; Gabbiani G
IARC Sci Publ (1971); 1978; (20):523-36. PubMed ID: 215532
[TBL] [Abstract][Full Text] [Related]
2. Cold lymphocytotoxic antibodies in nasopharyngeal carcinoma.
Lamelin JP; Revillard JP; Chalopin JM; Ho JH; Souissi T; Schwaab G; De-Thé G
Br J Cancer; 1977 Apr; 35(4):426-32. PubMed ID: 192260
[TBL] [Abstract][Full Text] [Related]
3. Smooth muscle antibody in Burkitt's lymphoma and in nasopharyngeal carcinoma.
Lamelin JP; Williams EH; Souissi T; De-Thé G; Gabbiani G
Clin Exp Immunol; 1977 Apr; 28(1):157-62. PubMed ID: 193662
[TBL] [Abstract][Full Text] [Related]
4. Differences in EBV antibody titres of patients with nasopharyngeal carcinoma originating from high, intermediate and low incidence areas.
de-The G; Lavoue MF; Muenz L
IARC Sci Publ (1971); 1978; (20):471-81. PubMed ID: 215529
[TBL] [Abstract][Full Text] [Related]
5. Nasopharyngeal carcinoma. IX. Antibodies to EBNA and correlation with response to other ebv antigens in chinese patients.
de-Thé G; Ho JH; Ablashi DV; Day NE; Macario AJ; Martin-Berthelon MC; Pearson G; Sohier R
Int J Cancer; 1975 Nov; 16(5):713-21. PubMed ID: 171226
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
[TBL] [Abstract][Full Text] [Related]
7. Malaria antibody levels in patients with nasopharyngeal carcinoma.
Yadav M; Prasad U
Southeast Asian J Trop Med Public Health; 1984 Jun; 15(2):234-7. PubMed ID: 6095462
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies in three populations of Burkitt's lymphoma patients.
Vainio E; Lenoir GM; Franklin RM
Clin Exp Immunol; 1983 Nov; 54(2):387-96. PubMed ID: 6317239
[TBL] [Abstract][Full Text] [Related]
9. Attachment of antinuclear antibodies to nasopharyngeal carcinoma or other cells during preparation of biopsy imprints.
Henle W; Henle G; Lanier AP; Bornkamm GW
J Natl Cancer Inst; 1986 Jun; 76(6):1041-6. PubMed ID: 3012176
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies on immunity to EBV-associated antigens in NPC patients in North America, Tunisia, France and Hong Kong.
Levine PH; Wallen WC; Ablashi DV; Granlund DJ; Connelly R
Int J Cancer; 1977 Sep; 20(3):332-8. PubMed ID: 198381
[TBL] [Abstract][Full Text] [Related]
11. [Significance of virus-specific antibodies to EBV-antigens in patients with nasopharyngeal carcinoma (author's transl)].
Wilmes E; Wolf H; Deinhardt F; Naumann HH
Laryngol Rhinol Otol (Stuttg); 1979 Dec; 58(12):911-5. PubMed ID: 231716
[TBL] [Abstract][Full Text] [Related]
12. Nasopharyngeal carcinoma and Epstein-Barr virus. III. The detection of anti-nuclear antibodies.
Lynn TC; Hsu MM; Hsieh T; Tu SM; Hamajima K
Jpn J Exp Med; 1976 Oct; 46(5):289-95. PubMed ID: 189106
[TBL] [Abstract][Full Text] [Related]
13. Histological types of nasopharyngeal carcinoma as compared to EBV serology.
Krueger GR; Kottaridis SD; Wolf H; Ablashi DV; Sesterhenn K; Bertram G
Anticancer Res; 1981; 1(4):187-94. PubMed ID: 6285799
[TBL] [Abstract][Full Text] [Related]
14. [EBV-specific antibodies in patients with nasopharyngeal cancer and tonsillar cancer. Follow-up of over 4 years].
Oberender H; Nowak R; Donner A; Brichacek E; Vonka V; Teterin W; Kunkel M
Laryngorhinootologie; 1989 Mar; 68(3):181-5. PubMed ID: 2540762
[TBL] [Abstract][Full Text] [Related]
15. Auto-antibodies in the sera of patients with nasopharyngeal carcinoma.
Yoshida TO; Yasuda-Yasaki Y; Utsumi KR
IARC Sci Publ (1971); 1975; (11 Pt 2):259-73. PubMed ID: 191369
[No Abstract] [Full Text] [Related]
16. Clinical evaluation of EBV serology in American patients with nasopharyngeal carcinoma.
Pearson GR; Coates HL; Neel HB; Levine P; Ablashi D; Easton J
IARC Sci Publ (1971); 1978; (20):439-48. PubMed ID: 215526
[TBL] [Abstract][Full Text] [Related]
17. [Strict correlation between anti-RANA antibodies and anti-EBNA antibodies apart from rheumatoid arthritis. Assessment of the diagnostic value of anti-RANA antibody].
Cohen JH; Lenoir GM; Colmet-Daage JF; Blanchard F; Etienne JC; Dropsy G; Gougeon J
Rev Rhum Mal Osteoartic; 1983 Jan; 50(1):3-7. PubMed ID: 6302824
[TBL] [Abstract][Full Text] [Related]
18. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the prognostic value of antibody-dependent lymphocyte cytotoxicity and other EBV antibody assays in Chinese patients with nasopharyngeal carcinoma.
Chan SH; Levine PH; de-Thé GB; Mulroney SE; Lavoue MF; Glen SP; Goh EH; Khor TH; Connelly RR
Int J Cancer; 1979 Feb; 23(2):181-5. PubMed ID: 216639
[TBL] [Abstract][Full Text] [Related]
20. Serologic diagnosis of nasopharyngeal carcinoma. A double-blind study of four EB virus antibodies with evaluation by sequential discrimination.
Cai WM; Li YW; Wu B; Liu YY; Hu YH; Gu XZ; Liu HY; Wang GD
Int J Radiat Oncol Biol Phys; 1983 Dec; 9(12):1763-8. PubMed ID: 6319338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
